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Abstract
Macrophages play a crucial role in several diseases’ development and progression, such as in cancer and arthritis through
ROS generation and inflammation. This makes macrophages a therapeutic target in these diseases. While silver nanoparticles
(AgNP) have been widely used as an antibacterial and investigated as anticancer, its potential against macrophages may be
limited due to its inherent oxidative mechanism. Here we encapsulated AgNP in a dipalmitoyl-phosphatidyl choline (DPPC)
liposome (forming Lipo-AgNP) to suppress AgNP-induced ROS and enhance its cytotoxicity against THP1-differentiated
macrophages (TDM). Our findings showed that while Lipo-AgNP had significantly more of a cytotoxic effect on TDMs
(p < 0.01), it also significantly suppressed AgNP induced ROS generation and unexpectedly suppressed reduced glutathione
(GSH) levels (p < 0.05) resulting in a redox imbalance in comparison to the unexposed control TDMs. Lipo-AgNP was also
found to cause an increase DNA damage through H2AX histone phosphorylation and inhibition of Bcl-2 protein expression. This increased the Bax/Bcl2 ratio causing possible release of cytochrome C and subsequent caspase 3/7-dependent
apoptosis. It was found that the difference between the mechanism of AgNP and Lipo-AgNP cytotoxicity may have been
through the significantly increased Lipo-AgNP uptake by the TDMs as early as 30 min post-exposure (p < 0.05), changing the
nanoparticle pharmacokinetic. In conclusion, the improved uptake of AgNP within the liposome caused ROS-independent
caspase activation induced by Lipo-AgNP and this was facilitated by increased DNA damage, the induced redox imbalance
and an increased Bax/Bcl-2 ratio.
Keywords Silver nanoparticle (AgNP) · Caspase 3/7 · Cell death · Apoptosis · Redox imbalance

Introduction
While macrophages are an essential component and are
key players in the innate immune system, they also play
a central role in maintenance of tissue homeostasis and
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developmental processes in defining physiological and
pathological conditions. Due to this, macrophages have
been widely studied as therapeutic target for diseases like
rheumatoid arthritis, atherosclerosis and cancer as the
role of this immune cell is known to be tilted to favour
disease development under specific conditions, particularly due to their induced inflammation [1]. The role of
macrophages in cancer for instance involves the release
of pro-inflammatory cytokines such as interleukin 1β (IL1β) and tumour necrosis-α (TNF-α) by tumour associated
macrophages (TAM) within the tumour microenvironment [2]. The release of these inflammatory cytokines like
IL-1β can drive endothelial cell proliferation and secretion of growth factors such as the vascular endothelial
growth actor A (VEGF-A) by the endothelial cells, facilitating angiogenesis [3]. In the same manner, production
of IL-1β and TNF-α aids recruitment of leukocytes that
perpetuate inflammation, which facilitates proliferation
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of synovial fibroblasts to form pannus that damages the
rheumatoid arthritis joint [4]. It appears that the exaggerated inflammatory response of these macrophages may in
part be facilitated by the high level of reactive oxygen species (ROS) that is generated by the immune cell. There is
evidence in the literature that macrophages generate a high
level of ROS such super oxides and hydrogen peroxides
within a tissue or organ even under minimal perturbation
to the normal processes that may characterise a diseased
condition [5, 6].
In support of this notion, ROS generation by macrophages
have been documented to play key role in driving progression of atherosclerosis through NADH oxidase activity in
production of RANTES (regulated on activation, normal
T-cell expressed, and secreted), a chemokine that facilitates
the homing of immune cells that boost inflammation within
the atherosclerotic plaque [5, 7]. Macrophages-generated
ROS also drives progression of cancer through secretion of
TNF-α and IL-1β to drive hyperproliferation and arthritis
through downregulation of regulatory T cells [8, 9]. Interestingly, targeting ROS generated by macrophages has been
shown to attenuate the development of atherosclerosis [10].
Likewise in cancer, liposomal bisphosphonates or monoclonal antibodies have been employed to directly induce cytotoxic effect on TAMs to deplete the macrophages, preventing
ROS generation or inflammation [1].
Silver nanoparticles (AgNP) are widely used as an antibacterial in a variety of applications including wound treatment and food preservation but have also been investigated
as anticancer agent in recent years. AgNP has been shown to
induce a cytotoxic effect on macrophages even at a very low
dose [11] and may be effective in treating disease conditions
mediated by macrophages as detailed above. Unfortunately,
the main mechanism of AgNP action involves induction of
ROS which effect myriad of intracellular responses such as
DNA damage, increased Bax/Bcl-2 ratio, permeabilization
of the mitochondrial membrane, degradation of key cellular protein and subsequent caspase 3/7-dependent apoptosis
[12]. While the induction of caspase-dependent apoptosis
may facilitate macrophage depletion within the atherosclerotic plaque, a tumour microenvironment or the arthritic
joint, the induced ROS may result in surge in secretion of
inflammatory molecules by the macrophages themselves
further favouring the disease condition.
We have previously shown that encapsulation of AgNP
in a diphosphatidyl choline (DPPC) based liposome suppressed AgNP-induced ROS generation in THP1 monocytes,
enhanced the nanoparticle cytotoxicity in THP-1 monocytes
[13] and suppressed AgNP-induced inflammation in THP-1
monocytes and THP1 derived-macrophages [14]. This study
investigated the cytotoxic effect of encapsulated AgNP
(Lipo-AgNP) on THP-1 derived macrophages (TDMs) and
further probed the mechanistic detail of the pathway utilised
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by Lipo-AgNP in inducing cell death, highlighting the divergence to the pathway utilised by AgNP.

Experimental
Materials
Silver nitrate (AgNO3) (CAS Number: 7761-88-8), sodium
borohydride (NaBH4) (CAS Number: 16940-66-2), dipalmitoyl phosphatidyl choline (DPPC) (CAS Number: 63-89-8),
cholesterol (CAS Number: 57-88-5), Phorbol 12-myristate
13-acetate (PMA) (CAS Number: 16561-29-8) and propidium iodide (PI) (CAS Number: 25535-16-4), protease inhibitor cocktail (Cat Number: P8340) were all purchased from
Sigma Aldrich, Dublin Ireland. Chloroform (CAS Number:
67-66-3) was from Fischer Scientific Dublin, Ireland while
Calcein-AM dye (CAS Number: 1461-15-0), H
 2DCFDA
(Cat Number: D399) and Thiol Tracker™ (Cat Number: T10095) and Alamar blue (Cat Number: DAL1025)
were all purchased from Biosciences LTD, Dublin Ireland. FIRELISA Human BCL-2 ELISA kit (Cat Number:
ELISAFNHU00475) were all purchased from ELISAGenie,
Dublin Ireland. Alexa Fluor® 647 anti-H2AX Phospho (Ser139) antibody (Cat. Number: 613408) was purchased from
Bio-legend through MSC, Dublin Ireland.

Methods
AgNP synthesis and encapsulation
To synthesise AgNP silver nitrate ( AgNO3) was chemically
reduced sodium borohydride (NaBH4) in a cold environment
after which the resulting AgNP was encapsulated in liposome made of dipalmitoyl-phosphatidyl choline (DPPC) and
cholesterol forming Lipo-AgNP nanocapsules as described
in our previous study, in addition to details of the characterisation [13]. Briefly, 30 mL of 2 mM solution of NaBH4
was added to an Erlenmeyer flask placed in an ice bath and
stirred at 350 rpm for 30 min to equilibrate after which 6 mL
 aBH4 solution one drop
of 1 mM A
 gNO3 was added to the N
per second under constant stirring. The stirring was stopped
after all the A
 gNO3 had been added, and the flask was taken
out of the ice bath. To further prevent agglomeration of the
AgNP the solution was placed back on the stirrer and stirred
until room temperature (RT) was achieved. The resulting
golden yellow solution was stable at 4 °C.
For encapsulation, dipalmitoyl phosphatidyl choline
(DPPC) and cholesterol were dissolved in 5 mL chloroform
and the solution was mixed until clear. It was then dried in a
vacuum oven at 52 °C overnight (above melting temperature
of DPPC). The resultant lipid cake was rehydrated in distilled deionised water ( ddH2O) at 60 °C in a shaker. After the
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lipid was rehydrated, an AgNP solution was added to make a
final lipid concentration of 1 mg/mL of DPPC and 0.23 mg/
mL of cholesterol to give a 7:3 molar ratio [15]. The solution was then placed in the shaker at 60 °C for another 20
min after which it was vortexed briefly and extruded through
a 100 nm Nanosizer polycarbonate extruder (TTScientific,
Knoxville, USA). The resulting colloidal mixture was stored
at 4 °C before use.
Scanning electron micrograph (SEM) and scanning
transmission electron micrograph (STEM) analysis
SEM micrographs for free and encapsulated AgNP were
obtained using a Hitachi SU-6600 field emission SEM
(Hitachi, Maidenhead, UK) at an accelerating voltage of 25
kV and working distance of 8 mm. For SEM analysis, a 5
µL drop-cast of each sample was made onto a 5 × 5 mm pure
silicon wafer substrate (Ted Pella Inc., Redding California,
USA) 24 h prior to obtaining the micrographs and allowed to
air dry. For STEM analysis, 3 µL of each sample was dropcast onto a carbon formvar copper grid (Agar Scientific Ltd.,
Stanstead, UK) 24 h prior obtaining and allowed to air dry.
Dynamic light scattering (DLS) analysis and zeta potential
analysis
To measure the hydrodynamic diameter of the nanoparticle
in solution, the DLS analysis of both AgNP and Lipo-AgNP
was carried out with Malvern Zetasizer Nano ZS (Malvern
Panalytical, Malvern, UK). The zeta potential measurement
of the nanoparticles was also measured with Malvern Zetasizer Nano ZS instrument set at 25 °C for all the samples.
Nanoparticles were loaded into a pre-rinsed folded capillary
cell up to the marked portion (usually filled with 1 ml of
sample). An applied voltage of 15 and 50 V was used for
Lipo-AgNP and uncoated AgNP respectively and a minimum of three different measurements were made for each
sample.
Cell culture and exposure
THP1 (ATCC®: TIB-202™) cells were used in this study
and were cultured in RPMI-1640 media supplemented with
2 mM L-glutamine and 10% FBS. The cells were incubated
at 37 °C, 95% humidity and 5% C
 O2. For nanoparticle exposure, cells were seeded in a 24-well plate (VWR, Dublin,
Ireland) at a density of 3 × 105 cells/ml of culture media and
1.5 ml of culture media per well. The cells were stimulated
with 100 ng/ml (162 nM) PMA for 72 h THP1 differentiated macrophages (TDM). The PMA containing media was
then replaced with fresh RPMI media and the cells left to
incubate for another 24 h [16].
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For all cell exposure, the culture media on the cells were
aspirated and the cells were rinsed in pre-warmed sterile 1×
PBS solution. After this, the cells were incubated in RPMI
media containing different concentration of either of AgNP
or Lipo-AgNP ranging from 0.3 to 10 µg/ml. A negative
control of unexposed cells was incorporated on the plate
while a positive kill control of a 10% (v/v) dimethyl sulfoxide (DMSO) solution and an internal positive control of
AgNO3 were o the plate. AgNO3 was incorporated to assess
the effect of Ag ionisation in AgNP on cell viability.
Cell viability
Cell viability of nanoparticle exposed TDMs was analysed
by Alamar Blue assay (AB). A pre-warmed solution of
AB (10% v/v) in serum free media was prepared and the
exposure media on the TDMs were removed, after which
the cells were rinsed with prewarmed sterile 1× phosphate
buffer saline (PBS). Then, 1.5 ml of AB solution was added
onto the cells and the plates were incubated at 37 °C for 2 h.
The florescence of the converted AB dye was measured at
540 nm excitation and 595 nm emission and wavelengths in
a SpectraMax® M3 Multi-Mode Microplate Reader.
Reactive oxygen species (ROS) assay
ROS generation in the THP1 differentiated macrophages
consequent of particle exposure was monitored using 6-carboxy-2′,7′–dichlorofluorescin diacetate (carboxy-DCFDA)
assay. This assay utilises esterase metabolism of carboxyDCFDA a non-fluorescent dye, into H 2DCFDA which
is further oxidised to a green fluorescent DCFDA dye by
ROS generated in the cell. To quantify the ROS generation, media on the TDMs seeded onto 24-well plate above
were aspirated and replaced with RPMI media containing
2% FBS. The cells were loaded with 10 µM of carboxyDCFDA dye and allowed to incubate for 30 min under above
culture conditions. After this, the culture media containing
carboxy-DCFDA were removed and the cells were rinsed
in prewarmed sterile PBS. The cells were then incubated in
media containing 2 µg/ml AgNP or Lipo-AgNP or 0.5 µg/
ml of AgNO3 (as positive control) for specific time points
to be analysed. Before ROS quantification, cells were rinsed
once again in PBS and the media was replaced with PBS.
ROS generation was then quantified by the fluorescence of
the oxidised carboxy-DCFDA, by monitoring the dyes emission at 535 nm and 485 nm excitation on a Spectramax M3
multiplate reader, using multi-well scan.
Reduced glutathione (GSH) assay
To measure the GSH levels, TDMs prepared as for ROS generation were exposed to both AgNP and Lipo-AgNP under
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the same conditions as above for 4 h. After exposure, the
cells were rinsed in prewarmed sterile PBS and incubated in
RPMI media containing 10 µM of Thioltracker™ violet dye
for another 30 min in the dark under incubation conditions
used above. The cells were rinsed again in prewarmed sterile
PBS after which they were covered in warm PBS. GSH level
of in the cells were measured using Multi-well scan setting
on a Spectramax M3 multiplate reader at 405 nm excitation
and 530 emission wavelengths.
Flow cytometry
Flow cytometry analysis was used for both ROS generation
and nanoparticle uptake. For ROS generation, TDMs already
treated with carboxy-DCFDA were exposed to nanoparticles
as above, rinsed in PBS and then gently scrapped off. The
scrapped cells were resuspended in PBS containing 1% BSA
and this method was subsequently used to detach the cells
before analysis.
For nanoparticle uptake, RPMI media from TDMs cultured as described above were aspirated and cells rinsed in
PBS. The cells were then incubated in media containing 2
µg/ml and the exposure media was removed at specific time
points after which the cells were rinsed in PBS and detached
as described above before flow cytometry analysis.
For live-dead staining, the TDMs were double stained by
adding 5 µl of 1 µM calcein-AM stain and 10 µl of 10 µg/ml
PI per 1 ml of RPMI media. The cells were then incubated
in the dark at RT for 20 min after which they were detached
by scrapping and processed as above for analysis by flow
cytometry.
For γH2AX activation analysis, unexposed TDMs and
TDMs exposed to 2 µg/ml AgNP and Lipo-AgNP and as a
positive control, 0.5 µM of doxorubicin for 24 h after which
the culture media on the cell was discarded. The cells were
detached by gently scrapping off from the plate as described
above and were washed in prewarmed sterile PBS followed
by centrifugation at 300×g for 5 min to pellet the cells while
the supernatant was discarded. The pellets were washed as
before and then fixed in ice cold 70% (v/v) ethanol for alcohol fixation at − 20 °C for 2 h. The cell suspension was
centrifuged at 500×g for 5 min to discard the ethanol, the
cells washed as previously three times in flow buffer made
up of PBS-BSA containing 0.1% sodium azide (NaN3) using
800×g centrifugation speed. The cells were permeabilised
by resuspension in 0.25% PBS-Triton-X100 (PBS-T) for 5
min at RT. PBS-T was completely removed by centrifugation
at 400×g for 5 min as above. The cells were then blocked
by resuspension in 2% (w/v) PBS-BSA and incubation at
RT for 30 min.
To immunostain the cells with anti-H2AX antibody,
the blocking solution was removed by centrifugation as
described above. The cells were resuspended in flow buffer
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containing the antibody at 1:100 and incubated at 37 °C for
30 min. The cells were washed to remove excess unbound
antibodies as above using PBS. The cells were resuspended
in fresh flow buffer solution analysed by flow cytometry in
BD Accuri C6 flow cytometer.
Finally, for Caspase3/7 analysis, as before the TDMs were
exposed to 2 µg/ml of either of AgNP or Lipo-AgNP for 24
h. The cells were harvested as above and then resuspended
in flow buffer of 1× PBS containing 0.1% sodium azide
(NaN3) and 1% BSA. The cells were then stained with 500
nM CellEvent caspase 3/7 detection reagent and incubated
at 37 °C for 30 min. After this, the cells were stained with
1 µM SYTOX Advanced dead cell stain and incubated for 5
min prior to being analysed by flow cytometry. All analyses
were performed on a BD Accuri C6 flow cytometer.
Cell lysate collection and sandwiched enzyme linked
immunosorbent assay (ELISA)
To collect cell lysate for protein expression analysis, culture
media was aspirated from the cells after which the cells were
rinsed in ice cold 1X PBS while the plate was kept on ice.
The cells were lysed with 100 µl of RIPA buffer containing
protease inhibitor cocktail per 3.5 × 105 cells and the cells
were scrapped off and pipetted up and down gently to break
up intact cell membranes. The lysate was transferred into a
1.5 ml Eppendorf tube and centrifuged at 13,000×g for 10
min at 4 °C. The supernatant was transferred into another
1.5 ml Eppendorf tube and kept on ice to be analysed by
ELISA. Sandwich ELISA of the collected lysate for Bax
and Bcl-2 protein expression from TDMs exposed to AgNP
or Lipo-AgNP was carried out following the manufacturer’s
instructions. Absorbance was measured at 450 nm.

Statistical analysis
Statistical analysis was carried out using GraphPad Prism
version 7. Data was analysed by Two-way analysis of variance (ANOVA) with Tukeys multiple comparison tests to
detect significance in effects between exposure groups. Statistically significant differences in tests were indicated for
p value < 0.05.

Results
Nanoparticle characterisation
Details of the characterisation of the AgNP and LipoAgNP have been reported in our previous study [13]. In
summary, the DLS analysis of both AgNP and Lipo-AgNP
are shown in Table 1. below. As shown, the hydrodynamic
radius of AgNP and Lipo-AgNP in ddH2O were found to
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Table 1  DLS analysis of both
AgNP and Lipo-AgNP

AgNP

Size (nm)
PDI
Zeta (mV)

Lipo-AgNP

In H2O

In RPMI

In H2O

In RPMI

20.47 ± 7.384
0.186
− 25.7

79.15 ± 66.67
0.566
− 7.90

139.0 ± 22.47
0.127
− 30.8

138.9 ± 54.93
0.421
− 0.61

be 20.47 nm and 139.0 nm respectively. Zeta potential
measurements also depicted the Lipo-AgNP to be more
stable with Zeta potential of − 30.8 mV compared with
the free uncoated AgNP having zeta potential of − 25.7
mV. In RPMI culture media, the mean particle size of
AgNP increased to 79 nm likely due to interaction with
the protein corona in the media while the size of the LipoAgNP remained unaffected likely due to the protection of
the liposome (Table 1). However, there was a significant
drop in the zeta potential of both AgNP and Lipo-AgNP
to − 7.90 mV and − 0.61 mV. This has been suggested
to be due to the effect of the charged amino acid in the
culture media protein [13]. The SEM of both AgNP and
Lipo-AgNP indicated both nanoparticles to be of spherical
morphology and in addition, the STEM showed the AgNP
to be successfully encapsulated within the liposome of the

Lipo-AgNP depicted as the grey area in the micrograph
(Fig. 1a, b). The encapsulation was also confirmed by
superposition of the DLS values of both AgNP and LipoAgNP to observe any overlap of the Lipo-AgNP values
with the AgNP values (Fig. 1c). Such overlap, if it occurs
would have demonstrated incomplete and unsuccessful
encapsulation of the AgNP. Interestingly the was no overlap of the values, further indicating successful encapsulation. Estimation of the AgNP size from the SEM indicated
a size of 14.3 ± 1.9 nm while Lipo-AgNP was estimated to
82.73 ± 29.23 nm in size. The slight difference in the sizes
may be due to the fact that DLS estimates the hydrodynamic radius which is influenced by the dispersion media,
in this case water, while the SEM shows the morphology
of the nanoparticle in dry state.

(A) (A)

(B)
50 nm

50 nm

50 nm

200 nm

(C)

Lipo-A gN P
A gNP

Intensity (%)
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5

0
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S iz e (n m )

Fig. 1  Characterisation of AgNP and Lipo-AgNP by SEM/STEM and DLS a SEM with STEM (inset) of AgNP b SEM with STEM (inset) of
Lipo-AgNP (black arrows indicating boundary of liposome c overlay of AgNP size value with Lipo-AgNP

13

Apoptosis (2020) 25:120–134

125

TDM viability when compared with AgNP at 2.5 µg/ml.
As a negative control, TDMs were also exposed to empty
liposome at concentrations equivalent to the liposomes in
2.5 and 5 µg/ml Lipo-AgNP. As shown in Supplementary
Fig. 1, it was found that the empty liposomes did not affect
the cell viability.
A calcein-AM/PI staining of TDMs was also carried
out to confirm the result of the AB assay at a cellular level
via an alternate technique. To evaluate cell viability here,
2 µg/ml was chosen as a test concentration. This concentration was just below that where a significant difference
in both AgNP and Lipo-AgNP toxicity existed. Here the
exposure of TDMs to Lipo-AgNP resulted in a significant
reduction in TDM cell viability compared with control
unexposed TDMs (p < 0.05), which was not observed for
AgNP at the same concentration (Fig. 3). On the contrary,
PI entry into the cells was similar in all groups. This was
likely because the exposure concentration of the nanoparticles was not toxic enough to cause cell death. To confirm
if the liposome was not cytotoxic on the cell, manifesting
as the observed cytotoxicity, the TDMs were exposed to
an equal amount of empty liposome as contained in 2 µg/
ml Lipo-AgNP and it was found that the liposome did not
affect the cell viability after 24 h exposure (Fig. 3).

Macrophage cell viability
As stated, the cell viability of TDMs upon exposure to
AgNP or Lipo-AgNP was evaluated by AB assay. The AB
assay is routinely used to estimate cell viability based on
the rate at which metabolically active cells reduce resazurin, a non-fluorescent blue dye to resorufin, a pink
fluorescent product. This chemical reduction of resazurin
occurs in both the mitochondrion and the cytoplasm, thus
it gives a broad indication of overall cellular viability [17].
TDMs were exposed to varying concentrations of AgNP,
Lipo-AgNP and AgNO3 (as positive control) ranging from
0.3 µg/ml to 10 µg/ml. As shown in Fig. 2, the A
 gNO3 used
as a positive kill control for Ag+ induced a significantly
higher reduction in TDMs viability at all concentrations
(p < 0.0001) with a 24 h I C50 of 0.12 µg/ml. In comparison
to AgNP induced reduction in cell viability at concentrations ≤ 5.0 µg/ml while Lipo-AgNP induced significant
reduction in TDMs viability at concentrations ≤ 2.5 µg/ml
(p < 0.001) compared to control unexposed TDMs, making Lipo-AgNP to have a lower I C50 value compared to
AgNP (3.98 µg/ml compared to 5.71 µg/ml respectively).
In addition, Lipo-AgNP induced a significant reduction in
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Fig. 2  Effect of AgNP, Lipo-AgNP and 
AgNO3 on cell viability
of TDMs. a TDMs were incubated with 0.3–10 µg/ml of either of
AgNP, Lipo-AgNP or A
 gNO3 for 24 h. Cells were incubated in 10%
AB solution in 2% FBS-RPMI for another 2 h. IC50 (24 h) was com-

puted for b AgNP c Lipo-AgNP and d AgNO3. Data is represented as
mean ± SD of 3 independent experiments. *** and **** are p < 0.001
and 0.0001 respectively
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channel while PI entry into the cell was detected in the FL-4 of a BD
Accuri 6 cytometer. Data is represented as mean ± SD of three independent experiments. MFI was calculated from intensity of 50 individual cells per experiment. ** is p < 0.01

Lipo‑AgNP suppressed AgNP induced redox
imbalance in TDMs

were positive for DCFDA fluorescence was comparable in
all groups as shown in Fig. 4a, the MFI readings indicated
that AgNP resulted in stronger intensity of ROS dependent
DCFDA signals compared to other groups. ROS generation
was highest for all groups at 1 h post exposure but this began
to decline up until 4 hours. In contrast to AgNP, Lipo-AgNP
exposure at all time points resulted in comparable levels
of intracellular ROS generation with the unexposed control
cells (Fig. 4b). The empty liposome was also found to induce
comparable levels of ROS to the control untreated cells for
all time points.
After demonstrating that Lipo-AgNP mediates a time
dependent suppression of AgNP induced intracellular ROS,
we investigated if this will be associated with the GSH levels in the cells and thus the redox balance. This was done
by exposing the TDMs to 1 µg/ml and 2 µg/ml of AgNP or
Lipo-AgNP or empty liposome at the same DPPC concentration as in 2 µg/ml Lipo-AgNP for 1 h. ROS and reduced

One of the known mechanisms of AgNP cytotoxicity responsible for its antibacterial and anticancer properties is its ability to induce generation of ROS upon entry into the cell. As
such we investigated whether the enhanced cytotoxic effect
of Lipo-AgNP was due to its ability to enhance ROS generation. TDMs were exposed to either of 2 µg/ml of AgNP
or Lipo-AgNP or 0.5 µg/ml of A
 gNO3 as positive control
after which the ROS generation upon exposure was analysed at different time points using flow cytometry (Fig. 4).
A negative of the empty liposome at the same DPPC concentration as in 2 µg/ml Lipo-AgNP was also incorporated.
As expected, AgNP exposure induced significantly higher
generation of intracellular ROS at all time points investigated when compared to the control unexposed and LipoAgNP exposed TDMs. Although, percentage of cells that
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or empty liposome containing DPPC and cholesterol as in 2 µg/ml
Lipo-AgNP for up to 4 h. a Plot of percentage of cell population with

positive DCFDA fluorescence b plot of the MFI of TDMs. Statistical significance was analysed by One-way ANOVA Turkeys multiple
comparison tests for each time point. Data represents mean ± SD of 3
independent experiments. * p < 0.05 and ** p < 0.01

glutathione (GSH) levels were then quantified by spectrophotometry. As observed previously, 2 µg/ml Lipo-AgNP
suppressed AgNP-induced ROS generation and in the same
manner contrary to what was expected (Fig. 5a), Lipo-AgNP
also significantly reduced the level of GSH in the TDMs
compared to both AgNP exposed and control unexposed
TDMs (p < 0.05) (Fig. 5b). As also observed in the confocal
microscopy result, the empty liposome induced comparable
levels of ROS and GSH as in the control untreated groups
(Supplementary Fig. 2). This observation is indicative of a
redox imbalance due to Lipo-AgNP exposure as a high GSH
level is expected due to ROS suppression and that the empty
liposome is relatively non-toxic to the cells.

Lipo-AgNP induced a higher cytotoxic effect on TDMs compared to AgNP, which is independent of intracellular ROS
generation and was accompanied by reduced GSH levels. It
has been previously shown that this redox imbalance created by suppressed ROS and GSH levels induced caspase
3-dependent apoptosis [18]. Based on this, we initially
probed activation of caspase 3/7 upon exposure of the TDMs
to 2 µg/ml AgNP or Lipo-AgNP. It was found that AgNP
induced significant activation of caspase 3/7 at 24 h compared to the unexposed (p < 0.0001) which was similar to
that induced by Lipo-AgNP (Fig. 6). However, exposure of
the TDMs to AgNP and the observed caspase 3/7 activation
did not translate to observable cell death as indicated by fluorescence due to the Sytox AAdvanced stain for dead cells.
Contrary to this, Lipo-AgNP exposure resulted to significant
number of dead cells after 24 h despite inducing activation
of caspase 3/7 at similar level with AgNP (p < 0.001).
Bax and Bcl-2 are respectively pro- and anti-apoptotic
factors in the intrinsic cell death pathway that act upstream

Caspase 3/7 pathway activation
ROS is one of the major upstream factors in the caspase
3/7 apoptotic pathway, and indeed the main mechanism of
AgNP induced apoptosis. The above data demonstrated that
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Fig. 5  Redox balance in AgNP and Lipo-AgNP exposed cells. a
Cells were treated as previously for ROS and the ROS level in cells
at 1 h post exposure to 2 µM of AgNP and Lipo-AgNP and 0.5 µg/
ml AgNO3 or empty liposome containing DPPC and cholesterol as
in 2 µg/ml Lipo-AgNP was measured spetrophotometrically b GSH
levels as measured in TDMs by first exposing the cells to 2 µM
AgNP or Lipo-AgNP or 0.5 µg/ml A
 gNO3 or empty liposome containing DPPC and cholesterol as in 2 µg/ml Lipo-AgNP for 1 h and
then to Thioltracker™ for 30 min before measurement. Statistical significance was analysed by Two-way ANOVA Tukeys test. Data represent mean ± SD of 3 independent experiments. * p < 0.05 and ***
p < 0.001

of caspase 3/7. We next probed the protein expression of
Bax and Bcl-2 after AgNP and Lipo-AgNP exposure. TDMs
were exposed to 2 µg/ml of AgNP or Lipo-AgNP for 24 h
after which cell lysate was obtained from the cells. Immunoassay of the lysate indicated that none of the nanoparticles influenced Bax protein expression when compared with
Bax expression in control unexposed group (Fig. 7a). On
the other hand, Lipo-AgNP exposure was found to significantly inhibit Bcl-2 protein expression (p < 0.001). Bax to
Bcl-2 ratio (Bax/Bcl-2) is widely used as an indicator of
apoptotic status of a cell [19]. Bax/Bcl-2 analysis carried
out showed that Lipo-AgNP exposure exhibited the highest
ratio compared to AgNP exposure or non-exposure of the
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control group (p < 0.05), explaining the observed cell death
upon exposure to Lipo-AgNP.
siRNA of Bcl-2 has been demonstrated to make cancer
cells sensitive to DNA damage resulting in apoptosis [20].
Based on this we investigated if Lipo-AgNP could be causing DNA damage which in addition to the low Bcl-2 expression might be the reason for the observed apoptosis. Activation of H2AX was evaluated in TDMs 24 h post exposure to
AgNP or Lipo-AgNP. This is because formation of H2AX
foci upon phosphorylation signals increased DNA double
strand break (DSB). A significant activation of γH2AX
was observed in cells exposed to Lipo-AgNP while AgNP
exposed TDMs showed comparable γH2AX fluorescence
with control unexposed TDMs (Fig. 7b). Thus, Lipo-AgNP
induced DNA damage in the TDMs which may have resulted
in apoptosis due to low Bcl-2 expression in the cells.

A time dependent intracellular ROS generation in the TDMs
indicated that ROS generation was highest for all exposure
groups at 1 h after which the level dropped considerably.
This indicates that the AgNP and Lipo-AgNP must have
been internalised by the cells prior to 1 h time point. As
such, we investigated the time course uptake of the nanoparticles by flow cytometry since the nanoparticles will increase
the internal complexity of the cell, which can be accurately
monitored by the SSC values. The uptake studies indicated
that Lipo-AgNP was significantly internalised by the TDMs
at 30 min (p < 0.01) while the AgNP was not internalised at
this time point since AgNP exposed TDMs had comparable
SSC value when compared with the control unexposed cells
(Fig. 8). At 45 min, AgNP and Lipo-AgNP uptake had significantly increased (p < 0.0001) but Lipo-AgNP uptake was
significantly higher than that of AgNP (p < 0.0001). At 1 h
post exposure to the nanoparticles, there was an observed
drop in the SSC values of the TDMs which was likely due
to the degradation of the nanoparticles. This continued up
till 24 h when none of the nanoparticles seem to be in the
cells based on the comparable SSC values with control unexposed cells. This finding indicates that entry of the silver
nanoparticle at 45 min must have resulted in ionisation of
the nanoparticle causing increased intracellular ROS levels,
which may have been suppressed by the liposome shell of
Lipo-AgNP.

Discussion
We recently showed in THP-1 monocytes that AgNP encapsulation in liposome enhances the nanoparticle cytotoxicity through steady release of AgNP and induced a caspase-dependent and ROS-independent apoptosis in THP1

Apoptosis (2020) 25:120–134
Sytox AAdvanced

129
Caspase 3/7

Merged

Control
Untreated

AgNP

Fluorescence Intensity

Empty
Liposome

****

25

Caspase
Sytox

****

20

****

15

**

10
5

ox
D

P
gN
A

gN

P

Li
po

A

Li
po
y

Em
pt

ro
l
on
t
C

Lipo-AgNP

U
nt

re

at
ed

0

Dox

Fig. 6  Activation of caspase 3/7 and induction of apoptosis by AgNP
and Lipo-AgNP. TDMs exposed to 2 µg/ml AgNP or Lipo-ANP or
0.5 µM Dox or empty liposome containing DPPC and cholesterol as
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fluorescence obtained from confocal microscopy (left) was converted
into digital data (right) using imageJ software. Statistical significance
was computed using Two-way ANOVA with Tukeys multiple comparison test. Data repesents mean ± SD of three independent experimental repeats and ***p < 0.001 and ****p < 0.0001

monocytes [13, 14]. Based on the different roles of monocytes and macrophages in disease development as well as
their varying responses to different stimuli, this study was
carried out to probe the molecular mechanism utilised by
Lipo-AgNP in inducing cell killing effect in TDMs. As previously observed for THP-1 monocytes, Lipo-AgNP also
demonstrated higher cytotoxicity on the TDMs compared
with AgNP. However, the IC50 for Lipo-AgNP in the TDMs
was slightly higher than what we previously recorded for
the monocytes. This may be due to the higher uptake rate of
the nanoparticle by TDMs because of their active phagocytosis compared to THP-1 monocytes, coupled with a more
sensitive nature of monocytes. Beduneau et al. [21] have
previously demonstrated that macrophages exhibit higher
uptake rate of IgG coated and uncoated super-magnetic ironoxide nanoparticles compared to monocytes, although the
study showed the nanoparticle exhibited similar toxicity in
both THP-1 and TDMs which was only after 1 h of exposure. A longer time point might have shown the nanoparticle

is more toxic in TDMs. In support of this, Wu et al. [22]
demonstrated the SPIONs induced release of pro-inflammatory cytokines after 24 h exposure of macrophages to the
nanoparticles.
ROS generation has been documented to be the main
mechanism utilised by AgNP to induce apoptosis in different cell types. Entry of AgNP into the cytoplasm results
in ionisation of the nanoparticle by the aqueous environment into silver ions, which subsequently causes generation of intracellular ROS that oxidise cellular proteins and
subcellular structures like the mitochondria or induce DNA
damage, culminating in caspase-dependent apoptosis [23].
Interestingly, the role of macrophages in diseases such as
cancer and atherosclerosis are largely modulated on the
ability of the immune cell to generate or respond to high
intracellular ROS within the tumour microenvironment to
suppress anticancer immune response or the atherosclerotic
plaque to induce expression of adhesive molecules that
facilitate plaque build-up [5, 24]. TDMs were employed in
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Fig. 7  Bax/Bcl-2 ratio and DNA damage in AgNP and Lipo-AgNP
exposed TDMs. a Lysates from TDMs exposed to 2 µg/ml of AgNP
or Lipo-AgNP or 0.5 µM of Dox or empty liposome containing DPPC
and cholesterol as in 2 µg/ml Lipo-AgNP for 24 h were collected
and immunoprobed by ELISA for Bax and Bcl-2 and the Bax/Bcl-2
ratios were computed b TDMs exposed as above were incubated in

anti-phosphoH2AX antibody as described in methods and the H2AX
phosphorylation was analysed by flow cytometry. Statistical significance was carried out by One-way ANOVA with Dunnet’s multiple
comparison test. Data is represented as mean ± SD for n = 3 independent experimental repeats

this study to investigate Lipo-AgNP effectiveness on macrophages that may be within the tumour microenvironment,
especially since Lipo-AgNP possess an anti-inflammatory
property in these cells [14]. As expected AgNP exposure
of TDMs resulted in ROS generation supporting findings of
other studies [11, 25]. Contrary to this and as we have previously shown in THP-1 monocytes, Lipo-AgNP suppressed
AgNP induced intracellular ROS generation. This indicates
that the encapsulation prevented or delayed the ionisation
of the coated AgNP which does not explain the enhanced
cytotoxicity.
Increased ROS generation is often coupled with reduction
in level of GSH. GSH is a tripeptide of glutamine, cysteine
and glycine, a biologically active antioxidant against the
activities of ROS. Oxidation of GSH by increasing level of
ROS results in crosslinking of the two molecules of oxidised
glutathione to GSSG causing a drop in the level of GSH and
vice versa under low ROS levels. As expected, we found that
exposure to AgNP resulted in reduced GSH level. AgNP is

known to induce ROS generation, GSH depletion and activation of caspase 3 [26]. Interestingly, Lipo-AgNP exposure
also resulted in reduced GSH levels which was unexpected
since the encapsulation prevented AgNP-induced ROS. The
reason for this is currently unknown but this redox imbalance has been previously demonstrated to induce activation
of caspase 3/7 dependent apoptotic pathway [18]. It is possible suppression of GSH by Lipo-AgNP is coupled with
activity of Bcl-2 since we observed inhibition of Bcl-2 protein expression. A previous study showed that Bcl-2 overexpressing human leukaemia cells have high level of GSH,
and another showed that the overexpression of Bcl-2 in a
lymphoma cell line aids intranuclear sequestration of GSH
[27, 28], which may inhibit ROS induced activation of caspase 3/7.
Increased expression and activation of Bax causes
destabilisation of mitochondrial outer membrane resulting in release of cytochrome C, activating downstream
factors preceding activation of caspase 3 and 7. Bcl-2 as an
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anti-apoptotic factor binds Bax to prevent mitochondrial
dysfunction. However, an increased Bax expression relative to a low Bcl-2 expression results in a high Bax/Bcl2
ratio causing Bax to induce mitochondrial outer membrane
permeabilization (MOMP), with release of cytochrome C
and a subsequent activation of caspases 3 and 7 down in
the intrinsic apoptotic pathway [29, 30]. As such, the Bax/
Bcl-2 ratio has been used as a prognostic factor for survival in different cancers and even as predictor of cancer
cells response to chemotherapy [31–33]. Interestingly, it
has been demonstrated that AgNP induces expression of
Bax increasing Bax/Bcl-2 ratio to induce apoptotic cell
death in male Wistar rats [34].
Based on the above and to establish a link between Bcl-2
expression and the low GSH level observed in Lipo-AgNP
exposed TDMs, we investigated for their Bax and Bcl-2
expression in response to AgNP and Lipo-AgNP exposure. Bax protein levels was unaffected in all the exposure
groups but Lipo-AgNP was found result in suppression Bcl-2
protein expression. This kept the Bax/Bcl-2 ratio high for
Lipo-AgNP exposed TDMs. A high Bax/Bcl-2 ratio has been
reported to be associated with increased apoptosis in cells
due to high Bax expression and a relatively unaffected Bcl-2
expression in cells exposed to therapeutic agent relative to
control cell lines [19]. Although this contradicts our finding here where the Bax level is similar in all exposure and
control groups, the low Bcl-2 level kept the Bax/Bcl2 levels high such that there is enough free Bax that will induce

mitochondria dysfunction and caspase 3/7 activation in
Lipo-AgNP exposed TDMs.
We previously showed that Lipo-AgNP induced DNA
fragmentation and cell cycle arrest at the S-phase of THP1
monocytes [13]. This is likely because cells with fragmented
DNA cannot successfully proceed through the S-phase due
to replication failure. We further confirmed here that LipoAgNP induced DNA damage as the exposure of TDMs to the
nanoparticle resulted in significant γH2AX activation. Phosphorylation of H2AX histone result in formation of γH2AX,
which recruits DNA damage repair proteins, hence its use
as a marker of DNA damage. Bcl-2 overexpression has also
been shown to suppress DNA repair, allowing cancer cells
accumulate mutations which result in genome instability, a
hallmark of cancer [35]. Deng et al. [36] also demonstrated
that Bcl-2 accelerates recovery of prostate cancer cells from
oxidative stress induced nuclear and mitochondrial DNA
damage. Taken together, Lipo-AgNP may have induced
DNA fragmentation causing H2AX phosphorylation and
the low level of Bcl-2 could not allow for Bcl-2 mediated
survival of the cell, further making the cells more sensitive
to the cytotoxic effect of Lipo-AgNP just as high Bax/Bcl-2
ratio is known to sensitize cancer cells to chemotherapeutic agents [33]. This coupled with the high Bax/Bcl-2 ratio
could synergistically induce activation of caspase-dependent
apoptotic pathway.
We have shown here that Lipo-AgNP is more cytotoxic
than AgNP, inducing a caspase-dependent apoptosis. While
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caspase 3 and 7 activation

AgNP was found to be less cytotoxic than the Lipo-AgNP,
the uncoated nanoparticle also induced a caspase-dependent
apoptosis which was dependent on intracellular ROS generation. This differing mechanism for Lipo-AgNP and AgNP
led to our hypothesis that Lipo-AgNP must have a distinct
pharmacokinetic mechanism when compared with AgNP.
In essence, these nanoparticles must have been metabolised
in different ways once they are internalised by the cells. To
test this, we monitored the uptake of both AgNP and LipoAgNP by evaluating the SSC values of the cells at specific
time point. Generally, the SSC value of cells increases with
particle uptake due to increase in their internal complexity
and there are studies that have successfully applied this technique to measure nanoparticle uptake [37–39]. Measuring
the SSC has several advantages. Firstly, in comparison with
fluorescently probing particle uptake, loss of fluorescent
intensity will affect the result of particle uptake since SSC
measurement does not require cell staining. Secondly, this

method is also more valuable in comparison with cell lysis
as particles can react with lysis reagent which may confound
data from subsequent quantification. Finally, this method
is cheap and fast. Measurement of Lipo-AgNP and AgNP
uptake showed that Lipo-AgNP was significantly internalised after 30 min of exposure. AgNP internalisation was not
observed until after 45 min of exposure, which confirms the
encapsulation of AgNP in liposome resulted in increased and
faster uptake of the nanoparticle. This finding is supported
by findings in different studies that reported that liposome
encapsulation of pharmacologically active agents enhances
drug uptake and delivery, producing better toxicity profile
and increased bioavailability [40–42].
Combining the uptake data with the ROS studies, while
Lipo-AgNP were already internalised at 30 min, it did not
result in any rise in intracellular ROS which indicates that
the encapsulated AgNP had not been exposed to the aqueous surrounding of the cytoplasm, thus not ionised. In
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correlation with AgNP uptake by the TDMs, significant
intracellular ROS generation was observed at 1 h which was
after 15 min of detected uptake and while the ROS level
dropped afterwards, it was still significantly higher than that
of other cell groups. While the ROS generated by AgNP
would have been responsible for the cytotoxicity observed
in AgNP-exposed TDM, the ROS level was likely not high
enough to suppress Bcl-2 expression or DNA damage. This
also explains why the cell killing effect of AgNP as depicted
by Sytox AADvanced staining was significantly less in
AgNP-exposed TDMs when compared with Lipo-AgNP
exposed cells (Fig. 6). In addition, the caspase activation
induced by Lipo-AgNP must have occurred earlier than that
of the AgNP due to the improved uptake causing cell death
earlier than in AgNP-exposed TDMs. This may be the reason
why caspase activation was comparable between AgNP and
Lipo-AgNP at 24 h but AgNP cell killing effect may occur
long after Lipo-AgNP. This is an indication of slower kinetics of AgNP mechanism compared with Lipo-AgNP. On the
contrary, Lipo-AgNP maintained comparable intracellular
ROS levels as the control unexposed TDMs indicating ROS
was not involved in its mechanism. Taken together, it seems
the interaction between the lipid bilayer of the liposome
and that of the TDMs facilitated uptake of the liposome.
However, entry of the liposome prevented ionisation of the
AgNP allowing direct nuclear delivery of the nanoparticle
at concentrations high enough to cause DNA damage which
resulted in phosphorylation of H2AX and suppression of
Bcl-2 expression. The low level of Bcl-2 in the cells did
not match Bax levels allowing free Bax to bind to the mitochondrial membrane causing MOMP and possible release
of cytochrome C and subsequent activation of caspase 3/7
to induce apoptosis (Fig. 9).

Conclusion
AgNP main mechanism of inducing apoptosis has been
reported in different studies to involve generation of ROS
and offset of the Bax/Bcl-2 ratio causing MOMP. Here we
confirmed that low dose AgNP induce significant generation
of intracellular ROS coupled with depletion of GSH but the
no significant cell death. ROS generation and inflammation
are tightly coupled, and this may be responsible for AgNPinduced associated inflammation reported in previous studies. On the contrary, we showed that Lipo-AgNP suppressed
ROS generation but depleted GSH level creating a redox
imbalance. This redox imbalance and DNA damage caused
by Lipo-AgNP may be responsible for the suppression of
Bcl-2 increasing the Bax/Bcl-2 ratio to facilitate effective
MOMP that may have induced observed caspase 3/7 activation and then cell death.
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